FEATURED PRODUCTS

• Powering Production Of Viral Vector-Based Therapies

  Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.

• CD34+ HSC LNP Kits

  Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

• GenVoy-ILM™ T-Cell Kits For mRNA

  Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.

• Single‑Use Filtration System For Pilot‑ And Small‑Scale Manufacturing

  Bring confidence to filtration with an automated single‑use filtration system for pilot‑ and small‑scale manufacturing. This system is intended for crossflow filtration applications in both upstream and downstream workflows.

• A Comprehensive Upstream Platform For Gene Therapy Applications

  Explore a variety of cell lines, high-performance cell culture media, and single-use bioreactors to suit your process needs for any cell type.

• AAV Manufacturing Workflow

  Explore scalable and flexible single-use solutions from design to delivery that can help you overcome challenges throughout adeno-associated virus (AAV) manufacturing workflow.

• Single-Use System For Clinical And Commercial Production Of LNPs

  Learn about a scalable, single-use platform with built-in automation and regulatory compliance that enables standardized manufacturing workflows for mRNA-LNP drug product production.

• Automated, Single-Use System For Clinical And Commercial LNP Production

  The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.

• Services For Advancing mRNA-LNPs From Bench To Clinic

  Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

• Single-Use Liquid Chromatography System

  Designed for small-scale manufacturing, this single-use liquid chromatography system offers the performance and documentation required for a GMP-regulated environment.

• Coated Magnetic Particles For RNA Preparation

  Learn about coated magnetic particles that easily isolate and extract mRNA from a variety of sources and enable you to perform RT-PCR cDNA library construction, affinity purification, and more.

• Oligonucleotide Synthesizer

  Synthesize oligonucleotides at scales of 10–100 mmol for early to mid-phase clinical trials or for diagnostic kits.

• Compact Oligonucleotide Synthesizer

  Looking for a user-friendly and compact oligonucleotide synthesizer with a large scale range? Discover a pilot-scale system that will take your drug through clinical development.

• Oligonucleotide Synthesizers That Take You From Start To Finish

  Explore systems for automated oligonucleotide synthesis, offered at a range of scales to support easy process development, optimization, scale up and transfer. Find the system that matches your needs.

• Chromatography Resins For Efficient Purification Of Oligonucleotides

  The rise in approved oligo therapeutics has led to increased pressure on oligo manufacturers. Learn about modern chromatography resins, how they can help increase productivity in manufacturing, and more.

• Accelerate Your Oligonucleotide Development And Scale-Up Goals

  Discover the platform for oligonucleotide development and scale-up that is the result of 30 years of collaboration with leading oligonucleotide pharma. Explore this solution's benefits, specifications, and more.

• Broad Scale Oligonucleotide Synthesizer For Better Production Outcomes

  OligoProcess covers a range of 10 to 1800 mmol and is suitable for quantities required in clinical phases and commercial production.

• Complete Solutions For Every Step Of Pharmaceutical Development

  By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

• A Disruptive Technology Accelerating Drug Development

  Ignite simplifies the transition into clinical programs by incorporating these fundamental process steps for scale up in the earliest stages of pre-clinical development.

   

• GenVoy-ILM™ T Cell Kit For mRNA, Ignite™

  GenVoy-ILM™ T Cell Kit for mRNA, Ignite is an lipid nanoparticle (LNP) reagent mix optimized for the delivery of messenger RNA (mRNA) or Cas9 mRNA/sgRNA into activated human primary T cells.